168 related articles for article (PubMed ID: 9045927)
1. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Huang XR; Mutch DA; Holdsworth SR
Kidney Int; 1997 Jul; 52(1):52-9. PubMed ID: 9211346
[TBL] [Abstract][Full Text] [Related]
3. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice.
Huang XR; Tipping PG; Shuo L; Holdsworth SR
Kidney Int; 1997 Jan; 51(1):94-103. PubMed ID: 8995722
[TBL] [Abstract][Full Text] [Related]
4. P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity.
Tipping PG; Huang XR; Berndt MC; Holdsworth SR
Eur J Immunol; 1996 Feb; 26(2):454-60. PubMed ID: 8617318
[TBL] [Abstract][Full Text] [Related]
5. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation.
Huang XR; Holdsworth SR; Tipping PG
Kidney Int; 1994 Jul; 46(1):69-78. PubMed ID: 7523756
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Mutch DA; Huang XR; Holdsworth SR
Kidney Int; 1998 Jan; 53(1):112-8. PubMed ID: 9453006
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
Holdsworth SR; Neale TJ
Lab Invest; 1984 Aug; 51(2):172-80. PubMed ID: 6611452
[TBL] [Abstract][Full Text] [Related]
9. Correlation between T cells and experimental crescentic glomerulonephritis.
Zou WZ; Zhou KX
Chin Med J (Engl); 1990 Oct; 103(10):805-10. PubMed ID: 2125253
[TBL] [Abstract][Full Text] [Related]
10. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice.
Haas C; Ryffel B; Le Hir M
J Inflamm; 1995-1996; 47(4):206-13. PubMed ID: 9144077
[TBL] [Abstract][Full Text] [Related]
11. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells.
Tipping PG; Huang XR; Qi M; Van GY; Tang WW
Am J Pathol; 1998 Jun; 152(6):1541-8. PubMed ID: 9626058
[TBL] [Abstract][Full Text] [Related]
12. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
13. Antibody independent crescentic glomerulonephritis in mu chain deficient mice.
Li S; Holdsworth SR; Tipping PG
Kidney Int; 1997 Mar; 51(3):672-8. PubMed ID: 9067898
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
Erlich JH; Holdsworth SR; Tipping PG
Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Sep; 23(9):2223-9. PubMed ID: 8370402
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
17. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
Tang WW; Feng L; Vannice JL; Wilson CB
J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.
Lan HY; Nikolic-Paterson DJ; Zarama M; Vannice JL; Atkins RC
Kidney Int; 1993 Feb; 43(2):479-85. PubMed ID: 8441245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
